Breakthrough Point-of-care Lung Function Assessment and home monitoring

BREAKTHROUGH Point-OF-CARE LUNG FUNCTION ASSESSMENT
AND HOME Monitoring

Point of Care (clinic and home) identification of OAD conditions and worsening trends through a comprehensive new platform that seamlessly captures airway oscillometry, inhaler adherence + technique, symptoms, and FEV1.

Developing a GOLD standard to capture early small airway obstruction trends both in clinic and at home.

Measure airway obstruction using PulmoScan

PulmoScan – first oscillometry device FDA-cleared for home use

Requires no forced breathing – ideal for elderly, fragile, and pediatric for daily quick lung assessment

Sensitive to small changes in airway function*

Latest PulmoScan data shows robust detection of OAD in n = 240.

Data to be presented at the ATS session: Poster #P590: Identifying Obstructive Airway Disease in Adults Via a Neural Network-based Diagnostic Classifier Employing Lung Oscillometry

A75 – REVISITING CURRENT METHODS IN PULMONARY FUNCTION TESTING

– May 19 11:30 AM – 1:15 PM
– Poster Board # P590, Area E (Hall A-B2, Ground Level).

High accuracy in OAD detection from oscillometry data recorded in a clinical setting (routine PFTs) using machine learning methods
Data-driven sub-classification of OAD patients as Asthma or COPD

Pilot shows 7-day early trends in Oscillometry data before AECOPD event

Data presented at the ATS 2023
Early Detection of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) Using At-home Lung Oscillometry
Significant early change from baseline for pooled AECOPD events
Early detection through oscillometry compared with daily CAT questionnaire
>85% compliance to daily tests

Capture small airway changes

Based on lung/airway oscillometry also known as Forced Oscillation Technique (FOT) or Impulse Oscillometry (IOS).
Localizes airway obstruction (distal/proximal)
Measures airway compliance/expandability

PulmoScan can assess obstruction via two markers measured for peripheral and central airways:

Resistance that measures the openness of the airways
Reactance that measures the expandability of the airways

Seamlessly Capture and Improve Inhaler Use with CapMedic

CapMedic provides interactive guidance and gamifies everyday inhaler use (albuterol and steroids).
Build correct and regular inhaler use habits, proven beneficial for chronic lung conditions such as asthma and COPD.

* DPI compatible sensor available separately

Obtain FEV1 measurements at home with the same CapMedic

Enables lung function capture in 3-seconds
Interactive interface to encourage full-effort
Immediate traffic-light assessment for actionable feedback

Engage Patients, Capture Symptoms through Text Automation

Automatic data sync eliminates any need for a smartphone app and boosts compliance
Automated text feedback to engage patients in care pathways and boost compliance
Minimal daily overhead for patients

Combined data captures lung function, medication, symptoms

Meet us at ATS 2024 conference:

Contact us to see a demo

See a live demo of the PFT and home use devices and implementation workflow for your practice/research. Fill the form out below and we will get in touch with you at your preferred time. Don’t worry, we don’t spam and you can unsubscribe at any time.